Market Cap 748.65M
Revenue (ttm) 401.28M
Net Income (ttm) -62.03M
EPS (ttm) N/A
PE Ratio 37.86
Forward PE 8.33
Profit Margin -15.46%
Debt to Equity Ratio 7.52
Volume 444,800
Avg Vol 688,098
Day's Range N/A - N/A
Shares Out 90.31M
Stochastic %K 47%
Beta 1.11
Analysts Sell
Price Target $8.15

Company Profile

Adamas Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. The company's targeted residential loans, including business purpose loans; agency RMBS; non-agency residential mortgage-backed securities (RMBS); structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties; and other mortgage-, residential housing- and credit-related assets...

Industry: REIT - Mortgage
Sector: Real Estate
Phone: 212 792 0107
Address:
90 Park Avenue, Floor 23, New York, United States
RoxieSoso
RoxieSoso Jan. 19 at 2:44 PM
$ADAM 👀👀👀
0 · Reply
Sepefrio
Sepefrio Jan. 16 at 4:41 PM
0 · Reply
Passivetryhard
Passivetryhard Jan. 15 at 6:28 PM
$ADAM 🧐
0 · Reply
Jim500
Jim500 Jan. 14 at 7:29 PM
$ADAM It’s on cruise control now
0 · Reply
scott53
scott53 Jan. 10 at 7:13 PM
$ADAM the trend has changed for this, as well as every other similar structure. You might want to reassess your strategy.👇
0 · Reply
ItsCarRamRod
ItsCarRamRod Jan. 5 at 3:55 PM
$ADAM 30 days to gain it and 3 hours to lose it, great job ADAM
0 · Reply
ThinkVision
ThinkVision Jan. 5 at 3:07 AM
0 · Reply
ThinkVision
ThinkVision Jan. 5 at 3:00 AM
0 · Reply
LucidDreame
LucidDreame Jan. 5 at 2:45 AM
$ADAM target a price of $5-$8 if the company successfully scales its products or secures strategic partnerships.
0 · Reply
LucidDreame
LucidDreame Jan. 5 at 2:44 AM
$ADAM Bullish facts Affordable alternatives like Symjepi to EpiPen. Growing demand for naloxone due to the opioid crisis. Specialty focus on high-demand areas (epinephrine, opioids, respiratory). Potential for partnerships with larger pharma companies.
0 · Reply
Latest News on ADAM
ADAMO: A 9.25% Senior Note IPO From Adamas Trust

Jan 19, 2026, 8:37 AM EST - 7 days ago

ADAMO: A 9.25% Senior Note IPO From Adamas Trust


14% Dividend Yield Is Not Enough

Oct 31, 2025, 7:53 AM EDT - 3 months ago

14% Dividend Yield Is Not Enough

AGNC ARCC ARR BXMT BXSL CHMI CIM


Adamas Trust, Inc. (ADAM) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 9:26 PM EDT - 3 months ago

Adamas Trust, Inc. (ADAM) Q3 2025 Earnings Call Transcript


Adamas Trust, Inc. Reports Third Quarter 2025 Results

Oct 29, 2025, 3:51 PM EDT - 3 months ago

Adamas Trust, Inc. Reports Third Quarter 2025 Results


Tempted By Adamas Trust's Baby Bonds

Oct 15, 2025, 3:48 PM EDT - 3 months ago

Tempted By Adamas Trust's Baby Bonds


Assessing New York Mortgage's Performance For Q2

Aug 28, 2025, 4:41 PM EDT - 5 months ago

Assessing New York Mortgage's Performance For Q2


New York Mortgage Trust Reports Second Quarter 2025 Results

Jul 30, 2025, 4:05 PM EDT - 6 months ago

New York Mortgage Trust Reports Second Quarter 2025 Results


Preferreds Weekly Review: Bonds Vs. Preferreds

Jul 20, 2025, 9:01 PM EDT - 6 months ago

Preferreds Weekly Review: Bonds Vs. Preferreds

SPMA SPMC


High Yields, Weird Prices

Jul 15, 2025, 6:06 PM EDT - 6 months ago

High Yields, Weird Prices

AGNC ARCC ARR BXMT BXSL CHMI CIM


NYMTH: A 9.875% Senior Note IPO From New York Mortgage Trust

Jul 13, 2025, 12:00 PM EDT - 7 months ago

NYMTH: A 9.875% Senior Note IPO From New York Mortgage Trust


REITs Score Key Tax Bill Wins

Jul 6, 2025, 9:00 AM EDT - 7 months ago

REITs Score Key Tax Bill Wins

ABR AVB BBRE BDN CZR DRN DRV


Where Fat Yields Meet Lower Risk

Jun 30, 2025, 4:26 PM EDT - 7 months ago

Where Fat Yields Meet Lower Risk

AGNC ARCC ARR BXMT BXSL CHMI CIM


A Brief Lesson On Huge Yielders

Jun 13, 2025, 12:39 PM EDT - 8 months ago

A Brief Lesson On Huge Yielders

AGNC ARCC ARR BXMT CHMI CIM DX


Big Dividend Yielders At A Glance

Jun 9, 2025, 6:05 PM EDT - 8 months ago

Big Dividend Yielders At A Glance

AGNC ARCC ARR BXMT BXSL CHMI CIM


Fat Dividends Served Reality Check

May 29, 2025, 6:54 PM EDT - 8 months ago

Fat Dividends Served Reality Check

AGNC ARCC ARR BXMT BXSL CHMI CIM


New York Mortgage Trust Reports First Quarter 2025 Results

Apr 30, 2025, 4:05 PM EDT - 9 months ago

New York Mortgage Trust Reports First Quarter 2025 Results


Let's Talk Mortgage REITs (But Not For Too Long)

Mar 26, 2025, 6:38 PM EDT - 10 months ago

Let's Talk Mortgage REITs (But Not For Too Long)

AGNCM ARR BXMT BXSL CHMI CIM CSWC


15% Yields Want To Mug Your Dividends

Mar 19, 2025, 4:05 PM EDT - 11 months ago

15% Yields Want To Mug Your Dividends

AGNC ARR BXMT CHMI CIM DX EFC


NYMTG: A 9.125% Senior Note IPO From New York Mortgage Trust

Jan 30, 2025, 11:14 AM EST - 1 year ago

NYMTG: A 9.125% Senior Note IPO From New York Mortgage Trust


RoxieSoso
RoxieSoso Jan. 19 at 2:44 PM
$ADAM 👀👀👀
0 · Reply
Sepefrio
Sepefrio Jan. 16 at 4:41 PM
0 · Reply
Passivetryhard
Passivetryhard Jan. 15 at 6:28 PM
$ADAM 🧐
0 · Reply
Jim500
Jim500 Jan. 14 at 7:29 PM
$ADAM It’s on cruise control now
0 · Reply
scott53
scott53 Jan. 10 at 7:13 PM
$ADAM the trend has changed for this, as well as every other similar structure. You might want to reassess your strategy.👇
0 · Reply
ItsCarRamRod
ItsCarRamRod Jan. 5 at 3:55 PM
$ADAM 30 days to gain it and 3 hours to lose it, great job ADAM
0 · Reply
ThinkVision
ThinkVision Jan. 5 at 3:07 AM
0 · Reply
ThinkVision
ThinkVision Jan. 5 at 3:00 AM
0 · Reply
LucidDreame
LucidDreame Jan. 5 at 2:45 AM
$ADAM target a price of $5-$8 if the company successfully scales its products or secures strategic partnerships.
0 · Reply
LucidDreame
LucidDreame Jan. 5 at 2:44 AM
$ADAM Bullish facts Affordable alternatives like Symjepi to EpiPen. Growing demand for naloxone due to the opioid crisis. Specialty focus on high-demand areas (epinephrine, opioids, respiratory). Potential for partnerships with larger pharma companies.
0 · Reply
LucidDreame
LucidDreame Jan. 5 at 2:42 AM
0 · Reply
justbaseball25
justbaseball25 Jan. 1 at 4:30 AM
i got 25 $MFA (commons and prefs just not catching a break) right at the end of the day at 9.295. made it through the final day of month of ex divs for monthlies and a bunch of quarterlies that pay in jan. such as $ADAM pref Z and holy shit that rebounded so well. $CCLDO - last normal div, double payments from here on for 12 months. something in me is telling me to sell $PHK too. sitting on 18k cash...this needs deployed. the 3.5% SPAXX that gets taxed is just ass. $67,410 expected passive income for 2026.
0 · Reply
BunkerBets
BunkerBets Dec. 25 at 9:01 AM
$ADAM Strategic positioning matters less than consistent throughput, since capital markets reward discipline over expansion for its own sake. Clear follow‑through could unlock sustainable re‑rating.
0 · Reply
kingking123
kingking123 Dec. 9 at 4:33 PM
$ARR $RITM $NLY $ADAM whazs happening?
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 4:59 PM
$ADAM Share Price: $7.49 Contract Selected: Jul 17, 2026 $10 Calls Buy Zone: $0.01 – $0.01 Target Zone: $0.01 – $0.02 Potential Upside: 74% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
RoxieSoso
RoxieSoso Nov. 27 at 3:52 PM
$ADAM I’m a long time holder really for the dividend. I haven’t really paid much attention to this one, so my question is what has made this run recently?
1 · Reply
Jim500
Jim500 Nov. 26 at 4:32 PM
$ADAM Ways to go from here!
0 · Reply
ItsCarRamRod
ItsCarRamRod Oct. 30 at 7:36 PM
$ADAM -6% down on more than double the average daily volume = a good start to a much lower price in the coming weeks.
0 · Reply
ItsCarRamRod
ItsCarRamRod Oct. 30 at 6:01 PM
$ADAM weee, isn't earnings fun. just shows that mREITs have no place in todays market.
2 · Reply
kingking123
kingking123 Oct. 30 at 5:55 PM
$ADAM what the heck?
1 · Reply
kingking123
kingking123 Oct. 30 at 3:32 PM
$ADAM why are we dumping? Bad ER?
0 · Reply
justbaseball25
justbaseball25 Oct. 29 at 9:10 PM
$ADAM with decent enough earnings. Preferreds very safe.
0 · Reply